Twice-daily insulin degludec/insulin aspart effectively improved morning and evening glucose levels and quality of life in patients previously treated with premixed insulin: an observational study

Twice-daily insulin degludec/insulin aspart effectively improved morning and evening glucose levels and quality of life in patients previously treated with premixed insulin: an observational study

Abstract Background Previous studies comparing insulin degludec/insulin aspart (IDegAsp) with premixed insulin twice daily among insulin users with type 2 diabetes have not thoroughly investigated differences in the glucose variability and psychological evaluations related to insulin regimen changes...

Full description

Bibliographic Details
Main Authors: Kanta Fujimoto, Toshio Iwakura, Megumi Aburaya, Naoki Matsuoka
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Insulin degludec/insulin aspart
Glucose variability
Quality of life
Type 2 diabetes
Online Access:http://link.springer.com/article/10.1186/s13098-018-0366-x

Internet

http://link.springer.com/article/10.1186/s13098-018-0366-x

Similar Items